Robert Wood Johnson I

Born in Carbondale, Pennsylvania in 1845, Robert Wood Johnson I worked in the pharmaceutical and drug trade in New York before attending the 1876 Philadelphia Centennial Exposition, where he heard Joseph Lister present his antiseptic surgery findings and recognized the commercial opportunity in manufacturing factory-sterilized surgical dressings. He spent the next decade acquiring the manufacturing knowledge, capital, and commercial relationships needed to act on the insight, before establishing Johnson & Johnson with his younger brothers James and Edward in New Brunswick, New Jersey in 1886. He served as the company's president from founding until his death in 1910, guiding its expansion from a small sterile dressing manufacturer into one of America's most respected medical supply companies.

Robert Wood Johnson I was the visionary and primary strategic architect of Johnson & Johnson's founding concept. His central insight — that Joseph Lister's antiseptic surgery principles would eventually be adopted across American medicine and that a factory-scale supplier of sterile surgical materials would be positioned advantageously ahead of that transition — proved correct within a decade of the company's founding. As American surgery's adoption of antiseptic technique accelerated through the late 1880s and 1890s, J&J's prepared position as a scaled, quality-controlled manufacturer of sterile dressings and sutures created first-mover advantages in hospital supply relationships that the company held for generations. Johnson I also demonstrated early instincts for healthcare professional education as a marketing platform, overseeing the 1888 publication of Modern Methods of Antiseptic Wound Treatment — a physician reference guide that simultaneously taught antiseptic technique and positioned J&J's products as the recommended materials for implementing it. Under his leadership, J&J expanded beyond surgical dressings into dental floss, baby powder, and early pharmaceutical preparations, establishing the diversified healthcare product base that would define the company's commercial strategy throughout the twentieth century. He was succeeded by his son Robert Wood Johnson II, who would transform J&J into the global diversified healthcare enterprise and write the Credo that became the company's lasting ethical foundation.